Entasis Therapeutics Holdings financials at a glance

Year Year 2018 2019 2020 2021 2017 2022 2023
Rev. Revenue
$5.00M $7.00M $0.00M $0.00M $0.00M $0.00M $0.00M
GM % Gross Margin %
100.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0
Sha. Shares
13.1m 13.29m 35.48m 47.64m 0m 47.85m 0m
OCF Operating Cash Flow
$-35.82M $-44.74M $-45.43M $-42.97M $-27.16M $0.00M $0.00M
FCF Free Cash Flow
$-36.19M $-44.85M $-45.44M $-43.04M $-27.45M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$-10.58 $-3.41 $-1.89 $-0.99 $0.00 $0.00 $0.00